Lexicon director exercises RSUs for 89,312 shares
LEXICON PHARMACEUTICALS, INC. director Raymond Debbane exercised restricted stock units into common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
LEXICON PHARMACEUTICALS, INC. director Raymond Debbane exercised restricted stock units into common stock. He converted 89,312 restricted stock units at an exercise price of $0.00 per unit into 89,312 shares of common stock and now holds 1,995,498 shares directly. Entities associated with him hold additional indirect positions of 35,402,689, 5,451,204, 7,362,368 and 1,538,462 common shares as of the reported date.
Insider Trade Summary
89,312 shares exercised/converted
Exercise
6 txns
Insider
DEBBANE RAYMOND
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 89,312 | $0.00 | $0.00 |
| Exercise | Common Stock | 89,312 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 1,995,498 shares (Direct);
Common Stock — 1,538,462 shares (Indirect, By Avicenna Life Sci Master Fund LP and related parties);
Common Stock — 7,362,368 shares (Indirect, By Invus Public Equities, L.P. and related parties);
Common Stock — 5,451,204 shares (Indirect, By Invus US Partners, LLC and related parties);
Common Stock — 35,402,689 shares (Indirect, By Invus, L.P. and related parties)
Footnotes (2)
- F1. Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- F2. Each restricted stock unit represents a contingent right to receive one share of common stock.
Key Figures
RSUs exercised: 89,312 units
Exercise price: $0.00 per unit
Direct shares after transaction: 1,995,498 shares
+4 more
7 metrics
RSUs exercised
89,312 units
Restricted stock units converted to common stock on transaction date
Exercise price
$0.00 per unit
Conversion price for 89,312 restricted stock units
Direct shares after transaction
1,995,498 shares
Common stock directly held by Raymond Debbane after RSU conversion
Indirect Invus, L.P. holding
35,402,689 shares
Common stock held indirectly via Invus, L.P. and related parties
Indirect Invus US Partners holding
5,451,204 shares
Common stock held indirectly via Invus US Partners, LLC
Indirect Invus Public Equities holding
7,362,368 shares
Common stock held indirectly via Invus Public Equities, L.P.
Indirect Avicenna Life Sci holding
1,538,462 shares
Common stock held indirectly via Avicenna Life Sci Master Fund LP
Key Terms
Restricted Stock Units, derivative security, indirect ownership, contingent right
4 terms
Restricted Stock Units financial
"The security title is listed as "Restricted Stock Units" for the derivative entry."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"The transaction code description notes an "Exercise or conversion of derivative security"."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
"Ownership type is marked as indirect for holdings via Invus, L.P. and related parties."
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Raymond Debbane report at Lexicon Pharmaceuticals (LXRX)?
Raymond Debbane reported exercising 89,312 restricted stock units into common stock. The units converted on a one-for-one basis into 89,312 Lexicon Pharmaceuticals shares at an exercise price of $0.00 per unit, reflecting the vesting of previously granted equity compensation.
What indirect Lexicon Pharmaceuticals (LXRX) holdings are associated with Raymond Debbane?
Entities associated with Raymond Debbane report indirect ownership of Lexicon shares, including 35,402,689 shares via Invus, L.P., 5,451,204 via Invus US Partners, LLC, 7,362,368 via Invus Public Equities, L.P., and 1,538,462 via Avicenna Life Sci Master Fund LP, as of the transaction date.
What are the terms of the restricted stock units reported by Raymond Debbane at LXRX?
Each restricted stock unit represents a contingent right to receive one Lexicon common share. The unit award vests with respect to 100% of the shares subject to the grant on the first anniversary of the grant date, then converts into common stock upon vesting.
Does the Form 4 for Raymond Debbane at LXRX show any stock sales?
The Form 4 shows an exercise of restricted stock units but no reported stock sales. The primary reportable event is the conversion of 89,312 restricted stock units into 89,312 common shares, increasing his direct equity holdings in Lexicon Pharmaceuticals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates